Interpace biosciences, inc. (IDXG)
CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash Flows From Operating Activities
Net loss

-26,727

-20,038

-15,718

-12,415

-12,189

-13,160

-13,434

-17,823

-12,216

-927

-5,104

-1,132

-8,332

-10,228

-7,630

-12,274

-11,356

-23,209

-22,649

-18,329

-16,073

-12,271

-10,077

-8,303

-4,565

-24,695

-23,574

-23,129

-25,527

-11,997

-11,180

-11,636

-11,914

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

4,187

3,795

3,503

3,482

3,464

3,457

3,463

3,573

3,690

3,806

4,030

4,198

4,483

4,745

4,921

5,092

5,030

4,838

4,053

3,129

2,391

1,831

1,685

1,594

1,425

1,466

1,615

1,821

2,034

2,184

2,478

2,762

3,046

0

0

0

Realignment accrual accretion

-

-

-

-

-

-

-

-

-

-

-

-

34

64

92

120

139

140

141

142

142

142

142

142

142

142

142

142

142

10

53

96

161

0

0

0

Gain on sale of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Interest accretion

440

0

0

0

-

-

-

-

312

855

1,353

2,172

2,144

1,871

1,611

1,037

1,095

964

685

400

139

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Bad debt expense

-

-

-

-

-

-

-

-

35

411

755

844

899

1,082

799

795

802

202

172

96

0

0

0

0

-

-

-

-

-

-

-

-

58

0

0

0

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

117

117

117

21

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Mark to market on warrants

-279

-182

133

180

112

-1

-1

70

141

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Mark to market on derivatives

-

-

-

-

-

-

-

-

-61

-61

-61

-42

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,634

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

1,535

1,952

2,220

2,211

2,270

2,147

1,894

1,599

1,060

499

249

122

131

2,609

3,051

3,688

4,017

1,877

1,820

1,830

2,124

1,968

2,008

2,062

1,723

1,790

1,828

1,713

1,791

1,773

1,713

1,638

1,936

0

0

0

Reversal of severance accrual

-

-

-

-

-

-

-

-

-2,034

-2,034

-2,034

-2,034

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-4,278

-4,278

-4,278

-1,547

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-5,602

-16,462

-17,636

-17,636

-11,860

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other gains and expenses, net

-18

0

0

0

-

-

-

-

-

-

-

-

4

4

4

13

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other changes in operating assets and liabilities:
Increase in accounts receivable

961

2,829

5,818

4,818

3,546

3,343

2,426

1,604

1,228

461

501

-406

-4,766

-3,410

-3,112

-4,013

5,486

6,698

5,841

2,602

3,422

-617

-2,248

-1,067

-8,256

-4,236

-2,803

1,758

1,054

-2,505

4,203

-7,865

-1,397

0

0

0

Decrease in unbilled receivable

-

-

-

-

-

-

-

-

-

-

-

-

16

867

-145

585

181

942

1,356

2,004

0

-307

-618

-1,510

6,027

5,660

5,339

4,473

-638

-1,953

237

-208

-770

0

0

0

Decrease (increase) in other current assets

-129

744

713

570

501

114

-129

-141

-222

-368

-1,672

-2,099

-1,478

-2,538

-2,414

-2,328

-2,350

-3,010

-2,968

-3,208

-3,678

-1,162

-1,441

-1,442

-1,740

-2,049

-1,592

-24

758

1,740

3,041

2,697

1,797

0

0

0

Increase in other long-term assets

-

-

-

-

-

-

-

-

-220

-2,470

-2,597

-2,565

-3,004

-1,903

-1,431

-1,819

-3,286

-2,339

-2,537

-2,209

-193

-156

-303

-305

-165

1

1,025

99

7

-1,894

-3,639

-2,704

-2,617

0

0

0

(Decrease) increase in accounts payable

-835

-772

416

417

668

249

-493

-2,584

-2,633

-1,304

-145

2,325

143

58

-93

406

1,019

485

1,123

-631

786

1,083

-1,092

-1,585

-1,038

-1,386

-420

776

-751

763

-508

513

873

0

0

0

(Decrease) in unearned contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

-11

-5,608

-7,366

-9,356

-5,201

1,235

2,753

3,809

-929

-4,407

-4,118

-5,090

-5,122

-4,232

-4,447

-2,680

-1,381

-5,133

1,150

260

2,465

0

0

0

Decrease in accrued salaries and bonus

-

-

-

-

-

-

-

-

-

-

-

-

-637

-1,945

-3,047

-517

895

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in accrued salaries and bonus

482

506

345

752

30

162

-302

-153

-1,395

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Increase (decrease) in accrued liabilities

-

-

-

46

-

-

-

-2,395

-2,751

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-4,992

-632

-2,362

-1,353

-3,389

-6,324

-4,234

-4,257

1,180

1

-638

-2,098

-1,805

-3,720

-2,571

-2,913

-5,913

2,041

3,662

3,159

1,817

0

0

0

Increase (decrease) in long-term liabilities

454

182

-84

-74

-82

511

245

259

223

-1,877

-1,775

-1,839

-2,334

-1,921

-1,226

-642

176

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Net cash used in operating activities

-18,957

-14,429

-11,431

-9,139

-8,673

-9,179

-11,718

-13,608

-15,263

-13,874

-10,908

-7,786

-7,607

-12,923

-16,973

-18,195

-19,842

-21,948

-16,230

-15,532

-16,378

-11,715

-11,226

-11,197

-3,512

-6,894

-4,019

-6,714

-10,286

-4,255

-6,423

-2,120

1,985

0

0

0

Cash Flows From Investing Activity
Purchase of property and equipment

131

166

418

401

449

388

108

89

29

29

0

0

0

-230

-189

-111

353

2,136

2,533

2,801

2,851

1,468

1,722

1,887

1,818

2,232

1,620

1,547

1,112

537

542

481

343

0

0

0

Sale of property and equipment

13

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan to privately held non-controlled entity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

655

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Net cash used in investing activity

-13,947

-13,982

-405

-388

-449

-388

-108

-89

-29

-29

0

0

0

26,981

26,940

26,862

26,398

-15,495

-24,392

-24,746

-25,365

-10,623

-3,877

-3,956

-3,318

-3,732

-1,620

-1,547

-1,112

-537

-542

-481

-343

0

0

0

Cash Flows From Financing Activities
Issuance of common stock, net of expenses

6,478

0

0

0

-

-

-

-

23,081

25,749

23,970

12,408

1,707

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for repurchase of restricted shares

-

-

-

-

-

-

-

-

-

0

0

0

-

171

176

182

208

50

45

39

228

284

299

302

314

276

276

278

156

0

0

0

-

-

-

-

Cash paid for repurchase of restricted shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments for Repurchase of Common Stock

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

29,157

0

0

0

-

-

-

-

29,889

23,913

22,134

10,572

-101

-21,320

-21,325

-21,331

-21,357

19,393

19,398

19,404

19,215

-284

-299

-302

-314

-276

-276

-278

-156

-130

-117

-112

-16

0

0

0

Net increase (decrease) in cash and cash equivalents

-

-

-

-3,521

-

-

-

5,519

14,597

10,010

11,226

2,786

-7,708

-7,262

-11,358

-12,664

-14,801

-18,050

-21,224

-20,874

-22,528

-22,622

-15,402

-15,455

-7,144

-10,902

-5,915

-8,539

-11,554

-4,922

-7,082

-2,457

1,626

0

0

0

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

0

975

1,658

2,310

3,128

2,153

1,470

818

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-